Our results indicate that triple procedure causes a more extensive and longer-lasting breakdown of the blood-aqueous barrier than PK only. Quantification of aqueous flare with the laser flare-cell meter is useful in the postoperative follow-up after triple procedure. Further studies are required to investigate the clinical relevance of BAB breakdown on endothelial cell count and the incidence of subsequent immunological graft rejection.
The frequency of episodes of graft rejection in our study was lower than usually reported in the literature. A good compliance of patients appears to be a major factor for improved prognosis of the graft after PK and in case of graft rejection. Until now no significant differences between short-term or long-term postoperative topical steroid therapy could be detected regarding the incidence of corneal graft rejection.
During the first year after PK, only a small decrease in endothelial cell density was observed in comparison with the 6-weeks finding. The storage method does not seem to affect the short-term changes of endothelial cell density. Further long-term studies are necessary to assess the clinical relevance of these observations.
Idiopathic sclerochoroidal calcification is a benign disorder which is diagnosed by the typical ophthalmoscopic picture in combination with standardised echography. Computed tomography can confirm the diagnosis. The most important differential diagnosis is choroidal osteoma, others are choroidal metastasis, choroidal amelanotic naevus and choroiditis. The early diagnosis of a sclerochoroidal calcification is important to avoid all the implications for the patient to which a misdiagnosis can lead.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.